https://www.clinicaltrialsarena.com/marketdata/newsfda-approves-intermezzo-sublingual-tablet-for-insomnia/
FDA approves Intermezzo sublingual tablet for insomnia - Clinical Trials Arena
Apr 5, 2023 - The US Food and Drug Administration (FDA) has approved Transcept Pharmaceuticals' Intermezzo (zolpidem tartrate) C-IV, used to treat insomnia.
sublingual tabletclinical trialsfdaapprovesintermezzo
https://www.genericmedicinesupplier.com/parkinson-medicine.html
Parkinson medicine - Apomorphine Sublingual Tablet Exporter & Trader - Wholesaler / Distributor...
sublingual tabletparkinsonmedicineapomorphineexporter
https://researchconnect.buffalo.edu/en/publications/development-of-a-stable-sublingual-nitroglycerin-tablet-i-interac/
Development of a stable sublingual nitroglycerin tablet I: Interaction of nitroglycerin with...
of anitroglycerin tabletdevelopmentstablesublingual